Skip to main content
. Author manuscript; available in PMC: 2020 May 20.
Published in final edited form as: Anticancer Res. 2017 Jun;37(6):3045–3052. doi: 10.21873/anticanres.11659

Table 4:

Multivariate Analysis Predicting OS and DFS

Variable P HR (95% CI)
OS
 Margins 0.175 1.9 (0.8–4.8)
 Metastatic Disease 0.317 2.1 (0.5–8.7)
 Skull Base 0.839 0.8 (0.1–10.8)
DFS
 T stage (1&2 vs 3&4) 0.503 2.1 (0.3–17.3)
 Overall Stage (1&2 vs 3&4) 0.954 1.1 (0.1–9.0)
 Skull Base 0.554 0.6 (0.1–3.1)
*

OS = overall survival, DFS = disease free survival, Vs = versus